AG-270

AG-270 · Institut de Recherches Internationales Servier

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AG-270, covering 2024-07-25 to 2024-07-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss [Phase 1]